2009 Vienna - European Society of Human Genetics
2009 Vienna - European Society of Human Genetics
2009 Vienna - European Society of Human Genetics
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Prenatal and perinatal genetics<br />
This was the largest study <strong>of</strong> population SMA carrier screening. Antenatal<br />
population carrier screening for SMA is feasible, effective and<br />
reasonable.<br />
P05.36<br />
Urge <strong>of</strong> prenatal diagnosis in modernized civilization<br />
B. B. Ganguly, D. Chakrabarti;<br />
MGM Centre for Genetic Research & Diagnosis, Navi Mumbai, India.<br />
Industrial revolution and modernization <strong>of</strong> medical sciences has contributed<br />
largely to expand the population and extend human lifespan.<br />
Massive quantities <strong>of</strong> toxic wastes are dispensed in the atmosphere<br />
unchecked as a direct consequence <strong>of</strong> our dependence on fossil fuels<br />
and advanced technologies which are rendering adverse effects on<br />
the nature. The recent decade has seen an unprecedented rise in natural<br />
calamities due to drastic fluctuations in weather conditions. These<br />
factors yield cumulative stress on the population causing tremendous<br />
damage to their health and well being. Infertility among adults, disorders<br />
like diabetes, cancer, HIV - AIDS, faulty births <strong>of</strong> infants having<br />
congenital abnormality and/or mental disorders are increasing at an<br />
alarming rate reducing the productive efficiency and pr<strong>of</strong>it derivative<br />
<strong>of</strong> the society.<br />
Hence it is the need <strong>of</strong> the hour to provide a strong and healthy start to<br />
the future generations so that they can cope up with the ever increasing<br />
hardships. This can be assured if the new born children are free<br />
<strong>of</strong> debilitating ailments acquired before or during parturition. Prenatal<br />
diagnosis is already a routine measure to screen and prevent birth <strong>of</strong><br />
genetically impaired children in well informed societies. However, this<br />
practice is limited at large due to lack <strong>of</strong> awareness among developing<br />
nations and availability <strong>of</strong> skilled diagnostic services in cost-effective<br />
manner. Conventional cytogenetics is one field <strong>of</strong> study that can prove<br />
to be an effective mode <strong>of</strong> prenatal diagnosis which should be given<br />
impetus by the organizations monitoring global health to bring immediate<br />
redress.<br />
P05.37<br />
Exposure to Fluoroquinolones during Pregnancy: An Analysis <strong>of</strong><br />
Birth Outcomes from a Romanian Pregnancy cohort study<br />
V. Dumitrascu 1 , A. Matusz 2 , C. Iftode 2 , A. Cheveresan 1 , D. Vlad 3 , C. Gug 4 ;<br />
1 “Victor Babes” University <strong>of</strong> Medicine and Pharmacy, Timisoara, Romania,<br />
Timisoara, Romania, 2 Scientific Secretariat, Association <strong>of</strong> General Health Care<br />
Providers, Timis County, Romania, Timisoara, Romania, 3 Emergency Clinical<br />
County Hospital, Timisoara, Romania, Timisoara, Romania, 4 Department <strong>of</strong><br />
Medical <strong>Genetics</strong>, “Victor Babes” University <strong>of</strong> Medicine and Pharmacy, Timisoara,<br />
Romania, Timisoara, Romania.<br />
Background: The new fluoroquinolones have favorable pharmacokinetic<br />
properties and high affinity for immature cartilage and bone tissue.<br />
Objective: to evaluate the teratogenic risk following gestational exposure<br />
to fluoroquinolones, numbers <strong>of</strong> fetal deaths, distress, and the<br />
development <strong>of</strong> the toddler’s skeleton at the age <strong>of</strong> twelve month.<br />
Methods: A longitudinal, randomized, 6 year comparative study, from<br />
November 2002 to December 2008, was conducted in two primary<br />
medical care centers. We followed up 110 women exposed to anti-infective<br />
drugs during gestation, divided in 2 groups: a study group <strong>of</strong> 58<br />
(52.72%) who took cipr<strong>of</strong>loxacin, norfloxacin, or <strong>of</strong>loxacin for different<br />
infections and a control group <strong>of</strong> 42 (38.18%) exposed to macrolides.<br />
Results: 23 women (25.21%) took fluoroquinolones in the first trimester<br />
<strong>of</strong> pregnancy, and there was a higher rate <strong>of</strong> therapeutic abortions<br />
among the study group (8 <strong>of</strong> 58 versus 3 <strong>of</strong> 42 - for the control group).<br />
Rates <strong>of</strong> major congenital malformations didn’t differ between the two<br />
groups (relative risk, 0.88; 95% confidence interval, 0.27 to 3.29). The<br />
major malformations from the quinolone group were: hip displasia, hypospadias<br />
and ventricular septal defects, occurred after fluoroquinolone<br />
exposure during organogenesis. The relationship between fluoroquinolone<br />
exposure and arthropaty focused on the newborn’s cartilage<br />
status (craniotabes) and on long-term musculoskeletal dysfunctions<br />
until at the age <strong>of</strong> twelve month (diastasis recti and genu valgum).<br />
Conclusions: Gestational fluoroquinolone exposure is risky in the first<br />
trimester <strong>of</strong> pregnancy. Ultrasonography is needed to monitor the fetal<br />
development, followed by long-term musculoskeletal survey.<br />
P05.38<br />
Recurrent trisomy 21: Postzygotic formation <strong>of</strong> i(21q) from both<br />
maternal chromosomes 21<br />
M. Trková, N. Jenčíková, M. Putzová, D. Rašková, D. Stejskal;<br />
The Centre <strong>of</strong> Medical <strong>Genetics</strong> and Reproduction Medicine GENNET, Prague,<br />
Czech Republic.<br />
Structural rearrangements involving chromosome 21 are responsible<br />
for 5% <strong>of</strong> trisomy 21 cases. The majority <strong>of</strong> rea(21q;21q) are, in fact,<br />
isochromosomes - i(21q) and only a small percentage are true Robertsonian<br />
translocations. The recurrence <strong>of</strong> de novo structural and<br />
numerical/structural chromosomal rearrangements might have three<br />
major reasons: a) recurrence by chance; b) gonadal mosaicism and c)<br />
low-level somatic-gonadal mosaicism in one parent.<br />
We present a family with recurrent trisomy 21 in three consecutive<br />
pregnancies with maternally derived rea(21q;21q) in all cases. Extensive<br />
G-banded karyotyping and FISH analysis <strong>of</strong> the maternal peripheral<br />
blood revealed trisomy 21 mosaicism (1.5% cells were trisomic for<br />
chromosome 21). Gonadal mosaicism for trisomy 21 in a significant<br />
proportion <strong>of</strong> mother’s ovarian cells provides a plausible explanation<br />
for her obstetric history.<br />
Molecular studies using highly polymorphic short tandem repeat (STR)<br />
markers localised on chromosome 21 permitted constructions <strong>of</strong> haplotypes<br />
in three patient foetuses from three consecutive pregnancies.<br />
It revealed trisomy 21 was due to the isochromosomes, thus strongly<br />
suggesting their postzygotic origin. Most surprisingly, molecular analysis<br />
also demonstrated that isochromosomes in two cases originated<br />
from different maternal chromosomes 21.<br />
Moreover, pregnancy outcome was also influenced by partners’ consanguinity.<br />
After two unsuccessful attempts <strong>of</strong> IVF-PGS they got spontaneously<br />
pregnant. The child with normal chromosome 21 suffered<br />
from an autosomal recessive disorder (LCHAD / long chain 3-hydroxyacyl-CoA<br />
dehydrogenase deficiency) as a direct consequence <strong>of</strong> consanguinity.<br />
To our knowledge, we demonstrate the first case <strong>of</strong> mosaics with two<br />
different maternal i(21q) derived from both maternal chromosomes<br />
21.<br />
P05.39<br />
the analysis <strong>of</strong> mitochondrial DNA polymorphism in<br />
monozygotic twins<br />
K. Wielgus 1 , K. Cieslik 2 , M. Waszak 2 , M. Szalata 3,4 , R. Slomski 3,4 ;<br />
1 Institute <strong>of</strong> Natural Fibres and Medicinal Plants, Poznan, Poland, 2 University<br />
School <strong>of</strong> Physical Education, Poznan, Poland, 3 Poznan University <strong>of</strong> Life Sciences,<br />
Poznan, Poland, 4 Institute <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong>, Polish Academy <strong>of</strong> Sciences,<br />
Poznan, Poland.<br />
Since the elucidation <strong>of</strong> the mitochondrial genome sequence in 1981,<br />
nearly 200 pathogenic point mutations, deletions, insertions and rearrangements<br />
have been described and associated with a variety <strong>of</strong><br />
mtDNA-related human diseases. Due to unique twin genetics, twins<br />
have been identified as an ideal subject for observations <strong>of</strong> complex<br />
diseases inheritance. Still, so far no wide range analysis <strong>of</strong> mtDNA in<br />
twins has been reported. In this study the analysis <strong>of</strong> mitochondrial<br />
DNA polymorphism in group <strong>of</strong> monozygotic twins was performed,<br />
using umblical cord blood. Zygosity <strong>of</strong> twins was determined by the<br />
analyses <strong>of</strong> DNA fingerprinting and mini- and microsatellite polymorphism<br />
(hybridization, PCR). The SSCP and HD analyses <strong>of</strong> D-loop<br />
mtDNA reveal a high polymorphism <strong>of</strong> this region. However, within the<br />
analyzed group <strong>of</strong> twins, no differences were found in either pair <strong>of</strong><br />
monozygotic twins. T>C transition was detected in mtDNA sequence<br />
in one pair <strong>of</strong> twins. The resultant tract <strong>of</strong> 10 C preceded by 4 A seems<br />
to be related to heteroplasmy <strong>of</strong> mitochondrial genome.<br />
P05.40<br />
Outcome <strong>of</strong> fetuses with a sonographic finding <strong>of</strong> echogenic<br />
bowel.<br />
V. Scotet1 , I. Duguépéroux1,2 , M. P. Audrézet1,2 , M. Blayau3 , C. Férec1,2 ;<br />
1 2 Inserm U613, Brest, France, Dept. <strong>of</strong> molecular genetics, Hospital, Brest,<br />
France, 3Dept. <strong>of</strong> molecular genetics, Hospital, Rennes, France.<br />
Introduction: Routine medical follow-up <strong>of</strong> pregnancies and development<br />
<strong>of</strong> ultrasonography have enabled the sonographic finding <strong>of</strong> fetal<br />
echogenic bowel (FEB), a sign that has been associated with various<br />
pathologies. Based on the experience <strong>of</strong> Brittany (western France),<br />
this study reports the type and frequency <strong>of</strong> the pathologies diagnosed<br />
0